Table 1.
Patient demographics (n = 62)
| Variable | Control (n = 20) n (%) |
DF (n = 22) n (%) |
DHF (n = 20) n (%) |
Total n (%) |
|
|---|---|---|---|---|---|
| Age (years)* | 24 (1.39) | 26 (13.16) | 23 (9.96) | 23 (9.89) | |
| Gender | Male | 10 (50.0) | 15 (68.2) | 7 (35.0) | 32 (51.6) |
| Female | 10 (50.0) | 7 (31.8) | 13 (65.0) | 30 (48.3) | |
| Haemorrhagic manifestation | Spontaneous bleeding | 1 (4.5) | 2 (10.0) | 3 (7.1) | |
| Petechiae | 0 (0.0) | 3 (15.0) | 4 (9.5) | ||
| Symptom | Headache | 22 (100.0) | 20 (100.0) | 42 (100.0) | |
| Arthralgia | 22 (100.0) | 20 (100.0) | 42 (100.0) | ||
| Nausea and vomiting | 7 (31,8) | 10 (50) | 17 (41,5) | ||
| Conjunctival injection | 1 (4.5) | 0 (0.0) | 1 (2,4) | ||
| Rash | 1 (4.5) | 3 (15.0) | 4 (9.5) | ||
| Sore throat | 1 (4.5) | 0 (0.0) | 1 (2.4) | ||
| Serological assays | IgM (+) | 4 (18.2) | 2 (10.0) | 6 (14.3) | |
| IgG (+) | 20 (90.9) | 19 (95.0) | 39 (92.9) | ||
| NS1 (+) | 18 (81.8) | 19 (95.0) | 37 (88.1) |
*
Mean (SD)